Videobeschreibung fragt, ob menschliches Altern gebremst oder umgekehrt werden kann

What if aging could actually be slowed — or even reversed? Billions of dollars are now pouring into the race to understand and manipulate the biology of aging. From GLP-1 drugs and senolytics to biological age clocks, cellular reprogramming and longevity supplements, scientists and investors are searching for a way to extend human healthspan. But how much of the anti-aging revolution is actually proven? In this documentary, we investigate the science behind the world's growing longevity industry — and separate promising research from the claims that are still ahead of the evidence. We look at: • How cellular aging damages the body • Senolytics and the attempt to eliminate senescent cells • GLP-1 drugs such as semaglutide and their surprising connection to aging research • New evidence showing semaglutide extended lifespan in older mice — and why that does NOT prove it extends human lifespan • Biological age and epigenetic aging clocks • Rapamycin, metformin and other potential longevity interventions • NAD+, NMN and other popular anti-aging supplements • Billionaires and biotech companies investing billions in longevity research • What has actually been demonstrated in humans • What remains experimental, unproven or potentially overhyped The longevity field is moving rapidly, but scientists still face one enormous challenge: proving that an intervention genuinely slows human aging rather than simply changing a biological marker or improving one aspect of health. The race to stop aging has begun. But the bigger question is: **Can we actually reverse it?** #Longevity #AntiAging #AgingResearch #GLP1 #Senolytics #Healthspan #BiologicalAge #LongevityScience #LifeExtension #Semaglutide Free Stock Footage by Vecteezy.com DISCLAIMER: This channel may use copyrighted materials under the “Fair Use” provision of YouTube Policy. Copyright Disclaimer under section 107 of the Copyright Act 1976 allows for "fair use" for purposes such as criticism, comment, news reporting, teaching, scholarship, and research. Non-profit, educational, or personal use tips the balance in favor of fair use.